Clinical implications of subclonal TP53 mutations in acute myeloid leukemia

Abstract

The role of subclonal TP53 mutations, defined by a variant allele frequency of 40%, 20%-40% and 40%, 19 had variant allele frequencies between 20%-40% and 18 had frequencies